Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Not Confirmed
Not Confirmed
11-13 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
11-14 November, 2024
The Pharmacy Technolog...The Pharmacy Technology
Industry Trade Show
Not Confirmed
11-13 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
24 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-plc-reports-third-quarter-2024-financial-results-302285218.html
25 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-host-investor-event-to-review-orexin-portfolio-strategy-302257677.html
23 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-present-positive-clinical-data-from-phase-1b-study-of-alks-2680-in-patients-with-narcolepsy-type-2-and-idiopathic-hypersomnia-at-sleep-europe-2024-302254991.html
28 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-morgan-stanley-22nd-annual-global-healthcare-conference-302233183.html
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/alkermes-announces-initiation-of-vibrance-2-phase-2-study-evaluating-alks-2680-for-the-treatment-of-narcolepsy-type-2-302227858.html
04 Jun 2024
// Nick Paul Taylor FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/alkermes-impresses-full-throttle-narcolepsy-race-takeda
Excipients
Inspections and registrations
ABOUT THIS PAGE
Alkermes Plc is a supplier offers 12 products (APIs, Excipients or Intermediates).
Find a price of Sirolimus bulk with DMF, JDMF offered by Alkermes Plc
Find a price of Dead On Polystyrene bulk with DMF offered by Alkermes Plc
Find a price of Dimethyl Sulfoxide bulk with DMF offered by Alkermes Plc
Find a price of Dl-Threo-3,4-Dihydroxyphenylserine bulk offered by Alkermes Plc
Find a price of Fluvoxamine bulk offered by Alkermes Plc
Find a price of Meloxicam bulk offered by Alkermes Plc
Find a price of Morphine Sulfate bulk offered by Alkermes Plc
Find a price of N1752 EXTENDED RELEASE TABLETS, 18MG bulk offered by Alkermes Plc
Find a price of ELND-005 bulk offered by Alkermes Plc
Find a price of N1714 TABLETS bulk offered by Alkermes Plc
Find a price of PROLEASE DILUENT USED FOR SUSPENSION OF PROLEASE MICROSPHERE PRODUCTS FOR PRODUCT ADMINISTRATION bulk offered by Alkermes Plc
Find a price of N1679 NANOCRYSTAL CAPSULE bulk offered by Alkermes Plc
LOOKING FOR A SUPPLIER?